Drugs / TNM005
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06068608 | Sep 2023 → Dec 2024 | chickenpox | Zhuhai Trinomab Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TNM005 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06068608 ↗ |
| Route | Intramuscular | “single,intramuscular injection” NCT06068608 ↗ |